Your session is about to expire
← Back to Search
Weight Bearing Strategies for Post-Hip Arthroscopy Recovery
N/A
Waitlist Available
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-week, 3 months, and 6-month post-operative
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at how soon after hip arthroscopic surgery patients can bear weight, to help them recover faster and get better outcomes.
Who is the study for?
This trial is for individuals aged 12 or older with hip impingement syndrome or a hip labral tear, who will undergo or have undergone hip arthroscopy with femoroplasty and labral repair at UPMC Children's or St. Margaret's Hospital. Both unilateral and bilateral cases are accepted. Those with musculoskeletal tumors, generalized hypermobility, or needing revision surgeries cannot participate.
What is being tested?
The study compares two post-surgery approaches to weight bearing: 'Weight Bearing as Tolerated' (WBAT) allows patients to put as much weight on the foot as comfortable immediately after surgery; 'Flat Foot Weight Bearing' (FFWB) means only the sole of the foot may bear weight right away.
What are the potential side effects?
While specific side effects aren't listed for these interventions, potential risks generally include discomfort while bearing weight, delayed healing if too much pressure is applied too soon, and possible complications leading to additional treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-week, 3 months, and 6-month post-operative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-week, 3 months, and 6-month post-operative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hip Outcome Score (HOS) ADL
Hip Outcome Score (HOS) Sport
Hip and Groin Outcome Score (HAGOS)
+2 moreSecondary study objectives
Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness
Diagnostic ultrasound assessment of incision widening
Diagnostic ultrasound for focal echogenic adhesions
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Weight bearing as tolerated (WBAT) immediately following surgery.Experimental Treatment1 Intervention
Subjects will be able to self-select weight bearing based on pain and confidence in surgical hip.
Group II: Flat foot weight bearing (FFWB) for 2 weeks after surgery.Active Control1 Intervention
Subjects will be limited to FFWB, approx 20lbs through the surgical hip.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,906 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had hip surgery to reshape the femur and repair the labrum.I have had surgery to correct or improve a previous procedure.I am 12 years old or older.I have been diagnosed with hip joint and labral tear issues.My surgery was done at UPMC Children's or UPMC St. Margaret's Hospital.I am extremely flexible or have very loose joints.I have a hip joint condition related to my cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Weight bearing as tolerated (WBAT) immediately following surgery.
- Group 2: Flat foot weight bearing (FFWB) for 2 weeks after surgery.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.